The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Rojkjaer Lisa since 2021.
This trader's CIK number is 1846460.
At the time of last reporting, Rojkjaer Lisa was the Chief Medical Officer of Viracta Therapeutics, Inc.. (stock ticker symbol VIRX).
Also see all insider trading activities at Viracta Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | VIRX | 0 | $0 | 2,156 | $3,624 | 4,127 | $0 |
| 2022 | VIRX | 0 | $0 | 6,701 | $21,197 | 12,381 | $0 |
| 2021 | VIRX | 0 | $0 | 4,541 | $21,847 | 43,004 | $84,095 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-02-25 | VIRX | Option Ex | 4,127 | .00 | 0 |
| 2023-02-27 | VIRX | Sale | 2,156 | 1.68 | 3,624 |
| 2022-11-28 | VIRX | Sale | 2,116 | 2.72 | 5,753 |
| 2022-11-25 | VIRX | Option Ex | 4,127 | .00 | 0 |
| 2022-08-25 | VIRX | Option Ex | 4,127 | .00 | 0 |
| 2022-08-26 | VIRX | Sale | 2,190 | 4.01 | 8,786 |
| 2022-02-25 | VIRX | Option Ex | 4,127 | .00 | 0 |
| 2022-02-28 | VIRX | Sale | 2,395 | 2.78 | 6,658 |
| 2021-11-26 | VIRX | Sale | 1,950 | 4.80 | 9,361 |
| 2021-11-29 | VIRX | Sale | 2,591 | 4.82 | 12,486 |
| 2021-11-25 | VIRX | Option Ex | 8,254 | .00 | 0 |
| 2021-05-11 | VIRX | Option Ex | 34,750 | 2.42 | 84,095 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Rojkjaer Lisa (Chief Medical Officer of Viracta Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.